A First in Human, Placebo-Controlled, Randomized, Double-Blind, Rising Single Dose Study of ADV-1002401 to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Healthy, Adult Volunteers and Adult Type-II Diabetic Volunteers - Phase 01 Study
Phase of Trial: Phase I
Latest Information Update: 31 Aug 2016
At a glance
- Drugs ADV 1002401 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Advinus Therapeutics
- 07 Mar 2013 Status changed from active, no longer recruiting to completed as reported by Clinical Trials Registry - India.
- 26 Jun 2010 Status changed from not yet recruiting to active, no longer recruiting as reported by Clinical Trials Registry - India.
- 23 Mar 2010 New trial record